You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 797 Genomic and transcriptomic profiles associated with response to eribulin and nivolumab combination in HER-2 negative metastatic breast cancer

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Combination Immunotherapies
797 Genomic and transcriptomic profiles associated with response to eribulin and nivolumab combination in HER-2 negative metastatic breast cancer

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023170010
Dec 20233005
Jan 20242503
Feb 20243805
Mar 20241800
Apr 20241001
May 2024800
Jun 2024800
Jul 20241201
Aug 20242201
Sep 20242000
Oct 20241002
Nov 20242003
Dec 20241605
Jan 20251402
Feb 2025002
Mar 2025001
Apr 2025001
May 2025003
Jun 2025002
Total421047